雷蛇(01337.HK)今年投入5,000萬美元支援受疫情影響之合作夥伴
雷蛇(01337.HK)宣佈將會於今年內投入5,000萬美元資金,支援受到新冠肺炎疫情帶來的經濟打擊而影響的商業合作夥伴。
該筆資金將會投入至雷蛇生態系統內的三大主要支柱—Razer Gold、Razer Fintech及zVentures,並以財務援助、現金流支援及投資三種形式支持企業。同時,企業亦可以連繫至雷蛇由硬件、軟件和服務組成、擁有高達8,000萬註冊用戶的生態系統,透過建立聯盟及合作夥伴關係,產生互惠互利的正面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.